Home > Touro College New York > Lander College of Arts and Sciences > The Science Journal of the Lander College of Arts and Sciences > Vol. 9 > No. 2
The Science Journal of the Lander College of Arts and Sciences
Article Title
Abstract
Anti-mitotic therapies are a form of therapy used to treat cancer patients. The use of these treatments on females can result in fertility complications. Therefore, prior to treatment, women must seek ways to preserve their ability to conceive children after receiving treatment. This study analyzes the outcomes of oocyte cryopreservation and its many variables. Three important variables that can affect the outcome of oocyte cryopreservation are age, cryopreservation method and cryoprotectants. Evidence indicates that human oocyte cryopreservation can enable a woman to preserve her ability to give birth to a healthy child, following anti-mitotic therapies. Hundreds of babies have been born as a result of oocyte cryopreservation. Oocyte cryopreservation can even enable a woman with ovarian cancer to have a healthy offspring, post treatment.
Recommended Citation
Gellis, E. (2016). Oocyte Cryopreservation. The Science Journal of the Lander College of Arts and Sciences, 9(2). Retrieved from https://touroscholar.touro.edu/sjlcas/vol9/iss2/7
